Skip to content

FASTFORWARDTM Bunion Correction System in Treating Hallux Valgus Patients

Clinical Study of MedShape FASTFORWARDTM Bunion Correction System in Treating Hallux Valgus Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03594292
Enrollment
12
Registered
2018-07-20
Start date
2018-05-31
Completion date
2019-12-31
Last updated
2018-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hallux Valgus and Bunion (Disorder)

Keywords

hallux valgus and Bunion

Brief summary

The FASTFORWARDTM Bunion Correction system has been cleared by the United States Food and Drug Administration for sale. This study is to investigate the clinical outcome of MedShape FASTFORWARDTM Bunion Correction system in treating hallux valgus patients at CMUH. Criteria-There will be 12 subjects with a painful bunion and hallux valgus between 20 and 65 years of age and an adequate range of movement. Patients with rheumatoid arthritis, failed previous hallux valgus surgery and symptomatic and/or radiological arthritis of the MTP joint will be excluded. Protocol-The PI and SC explain the detail and purpose of the project to the patient to the language to the patient is comfortable with. The explanation has to be at least 1 hour. Be sure the patients understand the full detail before the surgery. Computer tomography scan, gait analysis and blood biochemical analysis will be taken in 1-2 weeks after patient is enrolled in the subject. Before surgery, the titration bone tether plate designed to match patent's second metatarsal contour will be manufactured using 3D printing technology. Printed titanium plate and PEEK screws used to secure tethering suture tape in the first metatarsal will be sterilized prior implantation. The surgery time, recovery period and effectiveness after implantation will be recorded. To observing the recovery situation, patients will back to out-patient clinic at 1st, 2nd, 3rd, 4th, 6th, 12th, 24th weeks. During these period, physical examination, wound dressing, VAS, X-ray scan will be arranged. The detail arrangements below: 1.1st week: physical examination, wound dressing, VAS 2.2nd week: physical examination, wound dressing, VAS 3.3rd week: physical examination, wound dressing, VAS, X-ray scan, remove stiches 4.4th week: physical examination, VAS 5.6th week: physical examination, VAS, X-ray scan 6.12th week: physical examination, VAS, X-ray scan 7.24th week: physical examination, VAS, X-ray scan, CT scan, gait analysis

Interventions

DEVICEFASTFORWARDTM Bunion

The participants will be assign to implantation of FASTFORWARDTM Bunion correction system surgery as a experimental group.

PROCEDUREConventional surgery

The participants will assign to conventional surgery as a control group, the procedure is a standard treatment for the 1st metatarsal hallux valgus.

Sponsors

China Medical University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients with a painful bunion and hallux valgus between 20 and 65 years of age and an adequate range of movement

Exclusion criteria

* Patients with rheumatoid arthritis, failed previous hallux valgus surgery and symptomatic and/or radio-logical arthritis of the MTP joint

Design outcomes

Primary

MeasureTime frameDescription
Intermetatarsal 1-2 angle postoperative6 monthEvaluating the angle among the 1st and the 2nd metatarsal assess by X-ray scan and CT scan

Secondary

MeasureTime frameDescription
Assessment Foot Pressure6 monthFoot pressure assess by gait analysis
Pain using a visual analog scale6 monthEvaluating pain level by using visual analog scale
Intermetatarsal 1-2 angle6 monthEvaluating the angle among the first metatarsal and the first phalanx assess by X-ray scan

Countries

Taiwan

Contacts

Primary ContactHsuan-Fang Ho
hlucy0630@gmail.com886-4-2296-7979
Backup ContactTuan-Ti Hsu
nakohsu@gmail.com886-4-2296-7979

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026